We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

CORMAY

Cormay develops and manufactures diagnostic reagents and laboratory equipment, including hematology analyzers and cli... read more Featured Products: More products

Download Mobile App





Cormay Diagnostics Introduces True 5+ DIFF Multi-Patented Hematology Solution at MEDICA 2022

By LabMedica International staff writers
Posted on 16 Nov 2022
Print article
Cormay at MEDICA 2022 (Photo courtesy of Cormay)
Cormay at MEDICA 2022 (Photo courtesy of Cormay)

Cormay Diagnostics (Warsaw, Poland) is participating in this year’s edition of MEDICA, where the company is presenting its range of high quality diagnostic reagents and advanced laboratory analyzers.

At MEDICA 2022, Cormay is showcasing the MYTHIC 70, a true 5+DIFF hematology analyzer that delivers 29 parameters in less than 60 seconds. Its superior technology ensures reliability and multi-patented solution with unmatchable cost savings. It features walk away function and allows loading of 50 samples for improving laboratory efficiency. Alongside the MYTHIC 70, Cormay is exhibiting the MYTHIC 3CRP, a 3 DIFF hematology analyzer that offers a two-in-one solution. The MYTHIC 3CRP analyzer is designed to analyze whole blood samples, including measurement of blood cell count, hemoglobin concentration, CRP concentration and 3-part leukocytes differentiation.

In addition to its range of hematology analyzers, Cormay is also highlighting its portfolio of chemistry analyzers, including the ACCENT M320 and ACCENT S120. The ACCENT M320 and ACCENT S120 are computer-controlled, fully-automated chemistry analyzers for in-vitro diagnostic use in clinical laboratories to measure activity or concentration of clinical chemistry parameters in serum, plasma, urine and cerebrospinal fluid samples. Together with the highest quality dedicated reagent line, calibrators and controls, they provide a complete solution suitable for small to mid-size laboratories.

Among its urine analyzers being showcased by Cormay at MEDICA 2022 are the Uri-Tex and URI-TEX 300 semi-automatic urine chemistry analyzers. Designed to be used with Cormay urinalysis strips, the intelligent Uri-Tex image analyzer locates the strip and the pads, reads the color data, and based on these, determines the parameter values. Its intuitive device operation makes analysis easy and allows for fast determination of multiple chemical compounds in urine. Similarly, the Uri-Tex 300 semiautomatic urine chemistry analyzer is also designed to be used with Cormay urinalysis strips and determines the multiple parameters values in urine in less than a minute. The operator is only required to dip the strips into the samples and place them on the strips loading plate which allows for a maximum of 10 strips to be loaded at one time.

Related Links:
Cormay Diagnostics

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.